Innovative provider of technology-driven solutions continues to integrate products and services that enable sponsors, CROs and sites to do more trials together
DrugDev, a leading provider of technology driven solutions that help investigators, sponsors and CROs do more trials together, announced today the establishment of the DrugDev Innovation Lab, a technology incubator designed to accelerate emerging solutions in clinical trial automation. Led by DrugDev Executive Chairman Hugo Stephenson, MD, the DrugDev Innovation Lab will provide the expert guidance, capital resources and ecosystem necessary for smaller companies to scale their novel products into industry gold standard solutions.
Clinical trials are a clear area where mobile engagement and big data have serious potential, but it’s still a largely untapped use case. There have been a lot of stories recently about the opportunities in that space, but also on the challenges companies have encountered in implementing them. At least one abandoned study and one failed company can attest to those.
In a release, Wil Yu, Special Assistant for Innovations at ONC, said, “We are very excited about the winning applications. The popHealth tool is a cutting-edge technology that was able to support a highly technical competition. The winning teams displayed impressive levels of understanding in the areas of meaningful use and provider-patient interaction, which resulted in unique and useful solutions. We look forward to seeing advancements to the teams’ solutions in the future.”